PMID- 20863527 OWN - NLM STAT- MEDLINE DCOM- 20101116 LR - 20221207 IS - 1095-8673 (Electronic) IS - 0022-4804 (Linking) VI - 164 IP - 1 DP - 2010 Nov TI - Effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of type 2 diabetes mellitus. PG - e67-71 LID - 10.1016/j.jss.2010.07.004 [doi] AB - BACKGROUND: To investigate the effects of subtotal gastrectomy and Roux-en-Y gastrojejunostomy on the clinical outcome of patients with type 2 diabetes mellitus (T2DM). METHODS: We performed retrospective analysis of 21 patients with T2DM operated due to stomach cancer and upper gastrointestinal tract ulcer between January 2001 and June 2008. RESULTS: The body mass index (BMl) of all patients was <30 kg/m(2). The mean postoperative follow-up period was 26.6 mo (range, 6 mo-5 y). Subtotal gastrectomy and Roux-en-Y gastrojejunostomy remarkably lowered the levels of fasting plasma glucose (FPG), 2 h postprandial plasma glucose (2hPG), and glycated hemoglobin (HbA1c). Overall, 12 patients (57.1%) achieved adequate glycemic control (HbA1c < 7%) without antidiabetic medication and five patients (23.8%) showed good improvement. The total effectiveness rate of the surgery in T2DM patients was 81.0%. CONCLUSION: Subtotal gastrectomy and Roux-en-Y gastrojejunostomy appear to be effective treatment modalities for controlling T2DM in patients with BMl <30 kg/m(2). However, more studies with long follow-up period and large number of patients are necessary to clarify the benefits of this procedure. CI - Copyright (c) 2010 Elsevier Inc. All rights reserved. FAU - Yang, Juntao AU - Yang J AD - Department of Hepatobiliary Surgery, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China. FAU - Li, Chunxue AU - Li C FAU - Liu, Hongming AU - Liu H FAU - Gu, Hongguang AU - Gu H FAU - Chen, Ping AU - Chen P FAU - Liu, Baohua AU - Liu B LA - eng PT - Journal Article DEP - 20100730 PL - United States TA - J Surg Res JT - The Journal of surgical research JID - 0376340 RN - 0 (Blood Glucose) RN - 0 (Glycated Hemoglobin A) RN - 0 (Hypoglycemic Agents) RN - 0 (hemoglobin A1c protein, human) SB - IM MH - Aged MH - Blood Glucose/metabolism MH - Body Mass Index MH - Body Weight MH - Diabetes Mellitus, Type 2/*complications/drug therapy/*surgery MH - Female MH - Follow-Up Studies MH - Gastrectomy/*methods MH - *Gastric Bypass MH - Glycated Hemoglobin/metabolism MH - Humans MH - Hypoglycemic Agents/therapeutic use MH - Male MH - Middle Aged MH - Retrospective Studies MH - Stomach Neoplasms/complications/surgery MH - Stomach Ulcer/complications/*surgery MH - Treatment Outcome EDAT- 2010/09/25 06:00 MHDA- 2010/11/17 06:00 CRDT- 2010/09/25 06:00 PHST- 2010/01/11 00:00 [received] PHST- 2010/06/01 00:00 [revised] PHST- 2010/07/02 00:00 [accepted] PHST- 2010/09/25 06:00 [entrez] PHST- 2010/09/25 06:00 [pubmed] PHST- 2010/11/17 06:00 [medline] AID - S0022-4804(10)00616-5 [pii] AID - 10.1016/j.jss.2010.07.004 [doi] PST - ppublish SO - J Surg Res. 2010 Nov;164(1):e67-71. doi: 10.1016/j.jss.2010.07.004. Epub 2010 Jul 30.